Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer — Stella

Recruiting

Back to Advanced Thyroid Carcinoma trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang

Key details

Sponsor

Zhejiang Provincial People's Hospital

Enrollment target

~94 participants

Started

July 2025

Primary completion

December 2027

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov